Provider evaluation is described as necessary either way
Using Ozempic with insulin may increase your risk of this side effect, which can be severe or even life threatening
Additionally, Mounjaro , one of the newer diabetes drugs, which was approved in May 2022 and has a unique dual mechanism of action (it activates the GLP-1 hormone as well as another hormone called the glucose-dependent insulinotropic polypeptide or GIP, both helping to improve blood sugar) may be even more effective than semaglutide in reducing weight
The FDA has raised concerns about certain bodybuilding and performance-enhancement products, including products linked to liver injury, heart attack, stroke, hormone disruption, sexual dysfunction, mood changes, and other serious reactions